View on mobile

To help keep our community authentic, we're showing information about accounts on Linktree.
The Australian Regenerative Medicine Institute operates from Monash University's Clayton campus, specializing in regenerative medicine and developmental biology research focused on biological aging mechanisms. Their kidney disease research program examines age-related biomarkers and molecular changes in stem cell populations. Professor Sharon Ricardo leads investigations into early detection methods and therapeutic interventions through recent fellowship-supported work. ARMI's technical capabilities center on CRISPR-Cas9-based lineage tracing technologies for analyzing genomic complexity and cellular diversity in tissue development. The institute's research findings appear regularly in Developmental Cell and other peer-reviewed publications. Their laboratory facilities support the development of new analytical tools and methodologies for tracking cellular changes. Deputy Director Professor Edwina McGlinn guides ARMI's research strategy across three core areas: fundamental biological discovery, translational medicine applications, and collaborative partnerships. The institute maintains active research programs investigating healthy aging mechanisms and disease prevention approaches. Their work connects basic science insights to practical therapeutic development through established academic and industry collaborations.